The Home-Use of Semiconducting QUantum Excitonic Device: Image Converter/Sound Converter/Electromagnetic Converter to Improve Communicative Efforts, Speech, Language and Related Cognitive Functions in Children With Autism

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the transitions of subsystems from one autowave regime to another Autowave interaction (of Complex Coherent Action). Autowave interaction is a process associated with the evolution and interaction of spatial and wave structures in the active media of the organism. Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media of physiological systems is more optimal for their vital functions than periodic one. Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and easier in case of change of environmental conditions, i.e. the so called adaptive control is more easily implemented in them. Secondly, spreading of oscillations strength along comparatively wide frequency band takes place in chaotic regime. When an organism is young and healthy, physiological systems show the elements of chaotic behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics of health. Decrease in changeability and appearance of stable periodicity of Autowave reverberator are often connected with Autism. The main purpose is to study brain plasticity (the changes that occur in the brain through Autowave reverberator) in children with autism. Research suggests that during development, the brains of children may change in response to their Autowave reverberator differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this study, the investigators will be examining the effects of non-invasive neuromodulation SQUED™ series 28.1 home-use for Treatment of Autowave reverberator of Autism. Integrative Team World Organization of Medical Synergetics (WOMS) - collaborations between physicians and researchers with expertise in biostatistics, physics, mathematics, engineering, and computer science.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 month
Maximum Age: 21
Healthy Volunteers: f
View:

• Clinical diagnosis of autism or related conditions.

• History of Late complications at Natal Trauma:

‣ Cerebral level of Natal Trauma - brain injury;

⁃ Cervical level of Natal Trauma - injury of vertebral;

⁃ Cerebral anoxia.

• Identified language deficit(s) and/or other cognitive or behavioral impairments (which will be specific to each sub-study).

• Adequate ability to perform the research tasks set for the Age level:

‣ Infant - greater than 1 month to 2 years of age;

⁃ Child - greater than 2 to 12 years of age;

⁃ Adolescent - greater than 12 through 21 years of age.

• Presence on the Skin of the interruption of Autowave front (interruption of hair separatrix - dorsal/ventral) and/or of the Autowave Reverberators:

‣ Photo of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the kernel having an excitation tongue;

⁃ Graphics on tracing paper of Spiral Autowaves, generated by the kernel of Autowave Reverberator - the kernel having an excitation tongue.

• Presence of Clinical protocol CRF-SQUED™:

‣ Diagnostics of Autowave reverberators and Nonlinear Control of Autowave reverberators in Active media (Autowave interaction of patient - Algorithmic approach);

⁃ Mathematical Modeling of Autowave Reverberator and Computational Simulation of the treatment code (Trade Secret), and creation Active medium SQUED™ for a patient;

⁃ Recording for a patient of treatment code (Trade Secret) - Autowave regime: Hysteresis of Spiral Autowaves; Drift of Spiral Autowaves; Annihilation of Autowave reverberator.

• Magnetogram of region of Home-use and Geographic coordinates of Home-use.

Locations
United States
Kentucky
World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS
RECRUITING
Louisville
Other Locations
Ukraine
Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics
RECRUITING
Lviv
Contact Information
Primary
Yuliya Yaroshuk, M.D.s. Ph.D.
Dr.Yuliya.Yaroshuk@gmail.com
502-338-0861
Backup
Yuriy Fihol, M.D.s. Ph.D.
Dr.Yuriy.Fihol@gmail.com
+ 38 067-717-6873
Time Frame
Start Date: 2017-09-26
Estimated Completion Date: 2027-12
Participants
Target number of participants: 80
Treatments
Autism
Individuals with autism will have either Image converter (iSQUED™) for Hysteresis of Spiral Autowaves, Sound converter (sSQUED™) for Drift of Spiral Autowaves or Electromagnetic converter (eSQUED™) for Annihilation Autowave reverberator.
Sponsors
Leads: American Federation of Medical Synergetics
Collaborators: World Autism Center, American Federation of Medical Synergetics, Center of Synergetics, Universität Stuttgart, Germany, World Organization of Medical Synergetics, Laboratory of Neurocomputational Active Media WOMS, Ivan Franko National University of Lviv, Ukraine, Danylo Halytsky Lviv National Medical University, SQUED, Inc., USA, Institute of Medical Synergetics, Department of Cognitive Neurology WOMS, Clinic of Synergetics, Department of Neurology/Neuropsychology WOMS

This content was sourced from clinicaltrials.gov

Similar Clinical Trials